What is Exelixis's change in AR?

Exelixis (EXEL) reported change in AR of $42.03M in Q1 2026.

How has Exelixis's change in AR changed year-over-year?

Exelixis's change in AR increased by 160.8% year-over-year, from $16.12M to $42.03M.

What does change in AR mean?

The change in cash owed to the company by its customers.

How do you interpret change in AR?

A consistent increase relative to revenue may signal collection issues or aggressive revenue recognition.

How does change in AR compare across companies?

Should be compared against Days Sales Outstanding (DSO) metrics for industry peers.

Exelixis EXEL Change in AR

Change in AR at other companies

PfizerPFE

$65.75M+141%

IncyteINCY

$27.03M+187%

BridgeBio PharmaBBIO

$65.78M-40.5%

Neurocrine BiosciencesNBIX

$81.4M+121%

Jazz PharmaceuticalsJAZZ

$6.5M+110%

ALN

Alnylam PharmaceuticalsALNY

——

Other financials

Income statement

See full

Revenue$610.8M+10.0%

Gross profit$590.9M+10.2%

Operating income$251.3M+34.5%

Net income$210.5M+31.9%

EPS (diluted)$0.79+43.6%

Balance sheet

See full

Cash & equivalents$226.2M+23.1%

Total debt$169.5M-9.4%

Total equity$1.9B-9.2%

Total assets$2.6B-8.6%

Cash flow

See full

Operating cash flow$251.8M+19.1%

CapEx$1.5M-48.9%

Free cash flow$250.3M+20.1%

Valuation

See full

Market cap$13.05B+10.1%

Enterprise value$12.99B+9.5%

P/E15.7×-2.8×

P/S5.5×+0.3×

Profitability

See full

Gross margin96.4%-0.3pp

Operating margin39.4%+6.3pp

Net margin35.1%+7.1pp

FCF margin38.6%+2.9pp

Returns & leverage

See full

Return on equity41%+10.8pp

Debt / equity0.1×0.0×

Current ratio3.3×-0.2×

Where this comes from

Reported directly by Exelixis in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsReceivable.

The official record: Exelixis’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Exelixis's change in ar.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Exelixis's change in AR?: Exelixis (EXEL) reported change in AR of $42.03M in Q1 2026.
How has Exelixis's change in AR changed year-over-year?: Exelixis's change in AR increased by 160.8% year-over-year, from $16.12M to $42.03M.
What does change in AR mean?: The change in cash owed to the company by its customers.
How do you interpret change in AR?: A consistent increase relative to revenue may signal collection issues or aggressive revenue recognition.
How does change in AR compare across companies?: Should be compared against Days Sales Outstanding (DSO) metrics for industry peers.